Novartis (Germany) View Homepage


Ontology type: grid:Company  | foaf:Organization     


Organization Info

Publications in SciGraph latest 20 shown

  • 2019-12 Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study in BMC NEPHROLOGY
  • 2019-03-15 Versorgungssituation von Patienten mit ankylosierender Spondylitis und Psoriasisarthritis in Deutschland in ZEITSCHRIFT FÜR RHEUMATOLOGIE
  • 2018-12 Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials in BMC NEPHROLOGY
  • 2018-12 Individualised treatment targets in patients with type-2 diabetes and hypertension in CARDIOVASCULAR DIABETOLOGY
  • 2018-12 Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study in BMC CANCER
  • 2018-12 Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study in BMC NEPHROLOGY
  • 2018-12 Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany in DIABETES THERAPY
  • 2018-11 Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis in RHEUMATOLOGY INTERNATIONAL
  • 2018-10-26 Initiale Diagnostik und Indikationsstellung zur Anti-Vascular-Endothelial Growth-Factor-Therapie bei Netzhauterkrankungen in DER OPHTHALMOLOGE
  • 2018-10-20 Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated “same-day” (< 24 h), “per-guidelines” (24–72 h), and “late” (> 72 h): findings from the MONITOR-GCSF study in SUPPORTIVE CARE IN CANCER
  • 2018-08 Tolerability and efficacy of deferasirox in patients with transfusional iron overload: results from a German 2-year non-interventional study in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2018-06 Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience? in CLINICAL DRUG INVESTIGATION
  • 2018-04 Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained in BIODRUGS
  • 2018-04 Correction to: Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained in BIODRUGS
  • 2018-02 Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies in DRUGS & AGING
  • 2018-01 Clinical equivalence with G-CSF biosimilars: methodologic approach in a (neo)adjuvant setting in non-metastatic breast cancer in SUPPORTIVE CARE IN CANCER
  • 2018-01 Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA in NEUROTHERAPEUTICS
  • 2017-12 Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials in BMC OPHTHALMOLOGY
  • 2017-12 Electrocardiographic assessments and cardiac events after fingolimod first dose – a comprehensive monitoring study in BMC NEUROLOGY
  • 2017-11 Epidemiology of heart failure in Germany: a retrospective database study in CLINICAL RESEARCH IN CARDIOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "foaf:homepage": [
          {
            "id": "https://www.novartis.de"
          }
        ], 
        "grid:crossrefFunderId": [
          {
            "@value": "100008792"
          }
        ], 
        "grid:establishedYear": [
          {
            "@value": "2010-01-01", 
            "type": "http://www.w3.org/2001/XMLSchema#gYear"
          }
        ], 
        "grid:hasAddress": [
          {
            "id": "http://www.grid.ac/institutes/grid.467675.1/address-0"
          }
        ], 
        "grid:hasParent": [
          {
            "id": "http://www.grid.ac/institutes/grid.419481.1"
          }
        ], 
        "grid:id": [
          {
            "@value": "grid.467675.1"
          }
        ], 
        "grid:isni": [
          {
            "@value": "0000 0004 0629 4302"
          }
        ], 
        "id": "http://www.grid.ac/institutes/grid.467675.1", 
        "rdfs:label": "Novartis (Germany)", 
        "sdDataset": "grid", 
        "skos:prefLabel": [
          {
            "@value": "Novartis (Germany)"
          }
        ], 
        "type": [
          "http://xmlns.com/foaf/0.1/Organization", 
          "http://www.grid.ac/ontology/Company"
        ]
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://www.grid.ac/institutes/grid.467675.1'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://www.grid.ac/institutes/grid.467675.1'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://www.grid.ac/institutes/grid.467675.1'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://www.grid.ac/institutes/grid.467675.1'


     

    This table displays all metadata directly associated to this object as RDF triples.

    12 TRIPLES      11 PREDICATES      12 URIs      6 LITERALS

    Subject Predicate Object
    1 grid-institutes:grid.467675.1 sgo:sdDataset grid
    2 grid:crossrefFunderId 100008792
    3 grid:establishedYear 2010-01-01
    4 grid:hasAddress grid-institutes:grid.467675.1/address-0
    5 grid:hasParent grid-institutes:grid.419481.1
    6 grid:id grid.467675.1
    7 grid:isni 0000 0004 0629 4302
    8 rdf:type grid:Company
    9 foaf:Organization
    10 rdfs:label Novartis (Germany)
    11 skos:prefLabel Novartis (Germany)
    12 foaf:homepage https://www.novartis.de/
     




    Preview window. Press ESC to close (or click here)


    ...